FREE SHIPPING ON ORDERS OVER $150

liposomal glutathione parkinson's Innovative approach in targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Parkinson's Disease Treatment | IV

$23.27

Quantity
- +
Description

Lo, Y.Y.C., Wong, J.M.S

liposomal glutathione parkinson's Innovative approach in targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Parkinson's Disease Treatment | IV

Yang Z, Qi Z, Yang X, Gao Q, Hu Y, Yuan X

liposomal glutathione parkinson's Innovative approach in targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Parkinson's Disease Treatment | IV

Bannister CA, Holden SE, Jenkins-Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ (2014) Can people with type 2 diabetes live longer than people without diabetes

liposomal glutathione parkinson's Innovative approach in targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Parkinson's Disease Treatment | IV

After 4 days, combined treatment of GSC1 cells led to a marked reduction in spheroid formation and a significant reduction in viable cell numbers, while at the same time increasing the cell death ratio

liposomal glutathione parkinson's Innovative approach in targeting via berberine-loaded mucoadhesive surface-modified liposomes: a multi-faceted study | BMC Pharmacology and Toxicology Parkinson's Disease Treatment | IV

You may also like

recommand products